Comparing the Effects of Ischemic Compression and Kinesiology Taping Techniques

February 13, 2026 updated by: İlker DEMİR, Hasan Kalyoncu University

Comparing the Effects of Ischemic Compression and Kinesiology Taping Techniques in Patients With Chronic Low Back Pain

This study evaluates the effects of ischemic compression and kinesiology taping techniques on pain intensity and lumbar range of motion in individuals with chronic low back pain. Participants are assigned to one of three groups: a conventional treatment group, a conventional treatment plus kinesiology taping group, or a conventional treatment plus ischemic compression group. Interventions are administered over a three-week period. Outcome measures are assessed before and after the intervention using standardized assessment methods. The purpose is to compare changes among groups and examine the effects of adding these techniques to conventional treatment.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Chronic low back pain is a common musculoskeletal condition associated with pain, reduced mobility, and functional limitations. Nonpharmacological interventions are frequently used to support symptom management and improve physical function. Manual therapy techniques and supportive therapeutic applications are commonly included in rehabilitation programs for individuals with chronic low back pain.

This study is designed to investigate the effects of ischemic compression and kinesiology taping techniques in individuals with chronic low back pain. Participants are assigned to different intervention groups receiving either conventional treatment alone or conventional treatment combined with additional therapeutic techniques. Interventions are delivered according to structured protocols over a defined treatment period. Outcome measures evaluate changes in pain intensity and lumbar range of motion using standardized assessment methods.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
102

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Malatya, Turkey (Türkiye), 4400
        • Inonu University Turgut Ozal Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Volunteers willing to participate in the study,
  • Those who have had back pain for at least 12 weeks,
  • Those who have been tested with a test patch and have no allergy to kinesiology tape,
  • Patients who can comply with the exercise programme to be applied were included in the study.

Exclusion Criteria:

  • Patients who have undergone surgery for back pain,
  • Pregnant women,
  • Patients with rheumatological diseases were not included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Conventional Treatment Group
Participants in this group receive conventional treatment consisting of standard physiotherapy modalities administered according to a structured treatment protocol over a three-week period. No additional taping or manual compression techniques are applied in this group.
Other: Conventional Physiotherapy Program
Conventional treatment consists of standard physiotherapy modalities administered according to a structured protocol during scheduled sessions over a three-week period.
Experimental: Conventional Treatment Plus Kinesiology Taping Group
Participants in this group receive conventional treatment consisting of standard physiotherapy modalities together with kinesiology taping applied according to a structured application protocol over a three-week treatment period.
Procedure: Kinesiology Taping
Kinesiology taping is applied using standardized techniques by a trained therapist according to a structured application protocol during the treatment period.
Experimental: Conventional Treatment Plus Ischemic Compression Group
Participants in this group receive conventional treatment consisting of standard physiotherapy modalities together with ischemic compression therapy applied according to a structured protocol during scheduled sessions over a three-week period.
Procedure: Ischemic Compression Therapy
Ischemic compression therapy is a manual technique applied by a therapist using sustained pressure to targeted areas according to a structured treatment protocol during scheduled sessions.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in Pain Intensity (Visual Analog Scale)
Time Frame: Baseline and after completion of the 3-week intervention period
Pain intensity is assessed using the Visual Analog Scale, a validated measure consisting of a scale ranging from no pain to worst imaginable pain. Change is calculated as the difference between pre-intervention and post-intervention scores.
Baseline and after completion of the 3-week intervention period

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in Lumbar Flexion Range of Motion
Time Frame: Baseline and after completion of the 3-week intervention period
Lumbar range of motion is assessed using standardized measurement methods to evaluate spinal mobility. Measurements are obtained before and after the intervention, and change is calculated as the difference between pre-intervention and post-intervention values.
Baseline and after completion of the 3-week intervention period
Change in Lumbar Extension Range of Motion
Time Frame: Baseline and after completion of the 3-week intervention period
Lumbar range of motion is assessed using standardized measurement methods to evaluate spinal mobility. Measurements are obtained before and after the intervention, and change is calculated as the difference between pre-intervention and post-intervention values.
Baseline and after completion of the 3-week intervention period
Change in Lumbar Right Lateral Flexion Range of Motion
Time Frame: Baseline and after completion of the 3-week intervention period
Lumbar range of motion is assessed using standardized measurement methods to evaluate spinal mobility. Measurements are obtained before and after the intervention, and change is calculated as the difference between pre-intervention and post-intervention values.
Baseline and after completion of the 3-week intervention period
Change in Lumbar Left Lateral Flexion Range of Motion
Time Frame: Baseline and after completion of the 3-week intervention period
Lumbar range of motion is assessed using standardized measurement methods to evaluate spinal mobility. Measurements are obtained before and after the intervention, and change is calculated as the difference between pre-intervention and post-intervention values.
Baseline and after completion of the 3-week intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hasan Kalyoncu University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Ilker DEMİR, PhD, Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 3, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 10, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 2, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 13, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 13, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 20, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 20, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 13, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2024/136 (Other Identifier: Inonu University Clinical Research Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because data sharing was not included in the study protocol and no data-sharing agreement or repository plan was established.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings